An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes
Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock
Cardiac Shock Care Centers: JACC Review Topic of the Week
Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study
Predicting Major Adverse Events in Patients With Acute Myocardial Infarction
Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL Trial
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.